HRD Tests for Ovarian cancER
Condition(s):Ovarian CancerLast Updated:February 20, 2024Recruiting
Include Studies Not Open or Pending
Condition(s):Ovarian CancerLast Updated:February 20, 2024Recruiting
Condition(s):Breast Cancer; HER2-low Breast CancerLast Updated:July 20, 2022Not yet recruiting
Condition(s):Ovarian CancerLast Updated:March 28, 2024Recruiting
Condition(s):HRD 100 Gene Expression High; Triple Negative Breast CancerLast Updated:March 21, 2022Recruiting
Condition(s):Advanced HER2 Negative Breast Carcinoma HRD+Breast CancerLast Updated:January 31, 2023Recruiting
Condition(s):Homologous Recombination Deficiency Alterations Metastatic Colorectal CancerLast Updated:February 24, 2023Not yet recruiting
Condition(s):Metastatic Colorectal CancerLast Updated:February 24, 2023Recruiting
Condition(s):Advanced HER2 Negative Breast Carcinoma; HRD+Breast CancerLast Updated:September 29, 2022Recruiting
Condition(s):Breast Cancer; Ovarian Cancer; Pancreas Cancer; Prostate Cancer; BRCA1 Mutation; BRCA-Mutated Ovarian Carcinoma; BRCA-Associated Breast Carcinoma; HRD Positive Advanced Ovarian CancerLast Updated:March 26, 2024Recruiting
Condition(s):CancerLast Updated:March 15, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.